The value of quantitative measurement of HBeAg and HBsAg before interferon-α treatment of chronic hepatitis B in children
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (6) , 1097-1102
- https://doi.org/10.1016/s0168-8278(05)80624-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Therapy for hepatitis, with emphasis on the role of interferonsCurrent Opinion in Infectious Diseases, 1993
- Questions of Quality: How Much HBsAg Is There in This Sample and Is Our Assay Sensitive Enough to Detect It?Vox Sanguinis, 1993
- Prospective, randomized controlled trial of interferon-α in children with chronic hepatitis BHepatology, 1991
- Treatment of Chronic Hepatitis B with Interferon: Experience in Western CountriesSeminars in Liver Disease, 1989
- Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.Gut, 1989
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis BGastroenterology, 1988
- Prednisone Withdrawal Followed by Recombinant Alpha Interferon in the Treatment of Chronic Type B HepatitisAnnals of Internal Medicine, 1988
- The Treatment of Chronic Type B Viral HepatitisAnnals of Internal Medicine, 1988
- Natural history of the HBsAg carrier.Gut, 1985
- Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine ArabinosideThe Journal of Infectious Diseases, 1981